CGT2-arkiv - BioStock

Continued focus on new licensing deals for CombiGene

CombiGene comments on the discontinued CGT2 project

2 February, 2024

Continued focus on new licensing deals for CombiGene

CombiGene comments on Eurostars funding

22 December, 2023

CombiGene's CEO on the participation at BIO2023 in Boston

CombiGene’s CEO on the participation at BIO2023 in Boston

15 June, 2023

CombiGenes vd Jan Nilsson i BioStocks tv-studio i Sotckholm

Status update from CombiGene’s CEO

12 May, 2023

Jan Nilsson, vd CombiGene

CombiGene´s CEO provides an operational update

17 February, 2023

CombiGene Q3 2022

CombiGene’s CEO on the favourable position

17 November, 2022

CombiGene focuses on further in-licensing

29 August, 2022

Cominie

CombiGene’s new project manager on a broadened pipeline

16 May, 2022

CombiGene

CombiGene’s Chairman of the Board comments on the future

29 April, 2022

CombiGene strives for a broader pipeline

CombiGene strives for a broader pipeline

21 April, 2022

12 Page 1 of 2